Status:
COMPLETED
Peabody Developmental Motor Scale-2 in 0 - 24 Months in Turkey
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Motor Development
Infant, Premature, Diseases
Eligibility:
All Genders
1-24 years
Brief Summary
This study is the determination of the Turkish version of the Peabody Developmental Motor Scale-2 and its Turkish validity reliability in infants age between 0 - 24 months and to spread its use for ev...
Detailed Description
There are developments in the field of diagnosing children with a high risk of developmental disorders such as cerebral palsy (CP), mental problems and autism spectrum disorder in infancy . In particu...
Eligibility Criteria
Inclusion
- Infants between 0-24 months (adjusted age for premature infants will be calculated),who are followed as neurologically and developmentally at risk infants
- Infants who are not in neonatal intensive care unit
Exclusion
- Infants with congenital heart problems
- Infants of families who do not accept the study
- Infants with musculoskeletal system anomaly
- Infants connected to respiratory equipment
Key Trial Info
Start Date :
September 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04886310
Start Date
September 10 2020
End Date
July 1 2021
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nilay Çömük Balci
Samsun, Atakum, Turkey (Türkiye), 55139